Dr. Wolfgang Meder is a global regulatory professional with more than twenty years of drug development experience comprising seventeen years within global regulatory affairs roles.
He joined AM-Pharma as VP Regulatory Affairs and Quality Management in March 2020.
Wolfgang´s previous engagements include Correvio International, Tillots/Zeria, Vifor Pharma, Actelion, Novartis and Pfizer where he held positions of increasing responsibility including Head of Regulatory Affairs positions. He has global regulatory experience in multiple therapeutic areas including inflammatory bowel disease, nephrology, respiratory, anti-infectives, CNS, and cardiology.
Wolfgang has a Master degree in Drug Regulatory Affairs and holds a PhD in biochemistry, both from the University of Bonn, Germany.